ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
152,300
+5,200 (3.54%)
Feb 27, 2026, 3:30 PM KST

ST Pharm Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,164,2911,790,0291,275,2351,647,6492,596,9151,936,493
Market Cap Growth
95.53%40.37%-22.60%-36.55%34.10%248.32%
Enterprise Value
3,124,2671,811,0531,375,6951,714,0242,628,9661,910,417
Last Close Price
152300.0088900.0067410.3486388.45136510.46101442.21
PE Ratio
84.8451.5765.1391.54784.06-
Forward PE
49.6936.2237.6967.19133.19-
PS Ratio
9.946.544.476.6115.6815.60
PB Ratio
5.693.563.304.837.976.53
P/TBV Ratio
5.863.683.445.078.376.79
P/FCF Ratio
210.9167.18----
P/OCF Ratio
34.8216.36982.17234.34357.22-
EV/Sales Ratio
9.816.624.836.8815.8715.39
EV/EBITDA Ratio
39.4233.9924.3348.35131.50-
EV/EBIT Ratio
61.0265.4041.0596.02471.35-
EV/FCF Ratio
208.2467.97----
Debt / Equity Ratio
0.140.240.500.390.330.43
Debt / EBITDA Ratio
1.012.223.403.795.38-
Debt / FCF Ratio
5.334.43----
Net Debt / Equity Ratio
-0.07-0.010.260.250.04-0.05
Net Debt / EBITDA Ratio
-0.49-0.051.802.380.722.89
Net Debt / FCF Ratio
-2.62-0.10-2.43-1.58-0.320.36
Asset Turnover
0.440.390.460.470.350.32
Inventory Turnover
1.161.461.541.721.752.45
Quick Ratio
0.961.432.530.823.0010.07
Current Ratio
2.042.484.161.474.6412.66
Return on Equity (ROE)
6.89%7.30%4.81%5.25%1.08%-4.38%
Return on Assets (ROA)
4.44%2.48%3.36%2.09%0.74%-2.99%
Return on Invested Capital (ROIC)
7.24%4.25%5.50%4.25%1.79%-7.00%
Return on Capital Employed (ROCE)
8.90%4.70%5.70%4.60%1.30%-4.40%
Earnings Yield
1.17%1.94%1.54%1.09%0.13%-0.63%
FCF Yield
0.47%1.49%-3.29%-3.24%-1.71%-1.96%
Dividend Yield
0.33%0.56%----
Payout Ratio
27.31%27.09%48.03%52.25%--
Buyback Yield / Dilution
-7.23%-3.70%--0.77%-0.05%-
Total Shareholder Return
-6.90%-3.13%--0.77%-0.05%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.